Surrey Heartlands

Joint Formulary & PAD

Triamcinolone acetonide - Macular oedema

You are here : Home > Formulary Search > Triamcinolone acetonide - Macular oedema

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravitreal injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Triamcinolone acetonide
Indication :
Macular oedema
Group Name :
Keywords :
Brand Names Include :
Intracinol, Kenalog
Important Information :
ophthalmic suspension 40mg/ml. Intracinol is not a licensed product. Kenalog is off label.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Triamcinolone acetonide is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Macular oedema.

  • No records returned.

Committee Recommendations (1)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.